EcoDrugPlus

Presenilin-2-Like

Ensembl ID : ENSECRG00000017831
Gene Symbol: LOC114666256
3 Cross references
206 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSECRG00000008552
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Prostaglandin D2 Receptor

Ensembl ID : ENSECRG00000013525
Gene Symbol: PTGDR
1 Cross references
117 Possible Orthologues:

Prostaglandin D2 Receptor

Ensembl ID : ENSECRG00000013512
Gene Symbol: PTGDR
3 Cross references
117 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSECRG00000021207
Gene Symbol: PTGDR2
3 Cross references
134 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSECRG00000005690
Gene Symbol: PTGER4
3 Cross references
275 Possible Orthologues:

Prostaglandin E2 Receptor Ep2 Subtype-Like

Ensembl ID : ENSECRG00000013503
Gene Symbol: LOC114666806
3 Cross references
244 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSECRG00000006708
Gene Symbol: PTGFR
3 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSECRG00000000037
Gene Symbol: PTGIR
1 Cross references
188 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSECRG00000011891
Gene Symbol: PTGS1
3 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSECRG00000013201
Gene Symbol: PTGS2
3 Cross references
240 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSECRG00000003640
Gene Symbol: PSMA1
1 Cross references
270 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).